Jeffrey Trigilio

Jeffrey Trigilio

Director of Finance/CFO at CULLINAN ONCOLOGY, INC.

Net worth: 2 M $ as of 2024-02-28

40 year
Health Technology
Consumer Services
Finance

Profile

Jeffrey Trigilio is Chief Executive Officer, CFO & Secretary at Cullinan Mica Corp.
and Chief Financial Officer & Treasurer at Cullinan Oncology, Inc. In his past career Mr. Trigilio held the position of Chief Financial Officer at Amylyx Pharmaceuticals, Inc., Vice President-Corporate Finance at Bluerock Therapeutics, Inc., Head-Sales at Bayer AG, Chief Financial Officer of Cullinan Oncology LLC and Director-Healthcare Investment Banking at RBC Capital Markets LLC.
He received an undergraduate degree from Cornell University and an MBA from The Trustees of Columbia University in The City of New York.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-02-21 133,919 ( 0.31% ) 2 M $ 2024-02-28

Jeffrey Trigilio active positions

CompaniesPositionStart
CULLINAN ONCOLOGY, INC. Director of Finance/CFO 2020-08-31
Chief Executive Officer -
All active positions of Jeffrey Trigilio

Former positions of Jeffrey Trigilio

CompaniesPositionEnd
AMYLYX PHARMACEUTICALS, INC. Director of Finance/CFO 2020-06-30
Bluerock Therapeutics, Inc. Corporate Officer/Principal 2019-12-31
Corporate Officer/Principal 2018-07-31
BAYER AG Sales & Marketing -
Director of Finance/CFO -
See the detail of Jeffrey Trigilio's experience

Training of Jeffrey Trigilio

The Trustees of Columbia University in The City of New York Masters Business Admin
Cornell University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jeffrey Trigilio's experience

Connections

66

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
BAYER AG

Health Technology

AMYLYX PHARMACEUTICALS, INC.

Health Technology

Private companies5

Finance

Health Technology

Finance

Cullinan Oncology, Inc.

Bluerock Therapeutics, Inc.

See company connections
  1. Stock
  2. Insiders
  3. Jeffrey Trigilio